Page 96 - ஹேக்கன்சாக் மெரிடியன் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 AI-powered virtual assistant will be used to streamline entire pre- and post-vaccine distribution process for patients SAN FRANCISCO–(BUSINESS WIRE)–Following recent FDA approval of the first two COVID-19 vaccines, GYANT, the AI-powered virtual assistant company, today announced that its vaccine care navigation tool, GYANT Vaccine, has continued to gain traction since its launch in October. The solution is being deployed by numerous health systems, including Hackensack Meridian Health, MLK Community Healthcare, and Edward-Elmhurst Health, to facilitate the pre- and post-vaccine process in the weeks and months ahead. With the Pfizer vaccine FDA approved and already being distributed, and Moderna’s vaccine recently granted Emergency Use Authorization, health systems are looking to virtual assistants to build an infrastructure to efficiently manage each stage of rollout. GYANT Vaccine virtually guides patients through the entire pre- and post-vaccination process, from screenin

United statesCheryl eckStefan behrensEdward elmhurst healthDelivery networksAdventist healthCommunity healthcareStrategy planning at edward elmhurst healthHackensack meridian healthEmergency use authorizationAssociate vice president strategyIntegrated delivery networksIntermountain healthcareCleveland clinicஒன்றுபட்டது மாநிலங்களில்செரில் ஈக்